Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Maria Vittoria Cannizzaro"'
Publikováno v:
Dermatology Practical & Conceptual, Vol 13, Iss 3 (2023)
Introduction: Psoriasis is a common chronic, immune-mediated, inflammatory skin disease that in certain localization results difficult to treat. Psoriatic lesions in difficult-to-treat areas might be hardly managed as no standardized therapeutic appr
Externí odkaz:
https://doaj.org/article/2ce2419055464824a380b95996f5d955
Autor:
Margherita Annicchiarico-Petruzzelli, Yufang Shi, Maria Vittoria Cannizzaro, Elena Campione, Marco Galluzzo, Mara Mancini, Ying Wang, Valentina Rovella, Gerry Melino, Roberta Gaziano, Caterina Lanna, Marina Talamonti, Luca Bianchi
Publikováno v:
Cell Cycle
The skin is a peripheral lymphoid organ, being the first immunological defense against infections as the initial interface between the organism and the external background. The maintenance of the skin immune homeostasis depends on a finely equilibriu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a39257bb2084b7c7d5a250308cb6c62
https://doi.org/10.1080/15384101.2019.1653099
https://doi.org/10.1080/15384101.2019.1653099
Autor:
Maria Vittoria Cannizzaro, Roberta Gaziano, Cosimo Di Raimondo, Elisabetta Botti, Luca Bianchi, Raffaele Dante Caposiena Caro, Eleonora Di Matteo
Publikováno v:
Journal of the American Academy of Dermatology. 80:1314-1321
Background Antibiotics are recognized as first-line treatments for hidradenitis suppurativa (HS), but the data on their efficacy are limited. Objective Evaluate the efficacy of oral clindamycin versus that of clindamycin plus rifampicin in patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a36c15b8277f78f1c7e0dc9e2946b2
https://doi.org/10.1016/j.jaad.2018.11.035
https://doi.org/10.1016/j.jaad.2018.11.035
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 12, Pp 363-369 (2019)
Clinical, Cosmetic and Investigational Dermatology
Clinical, Cosmetic and Investigational Dermatology
Virginia Garofalo, Maria Vittoria Cannizzaro, Sara Mazzilli, Luca Bianchi, Elena CampioneDivision of Dermatology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, ItalyBackground: Acne is a debilitating disorder that requires pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d279589279c39881c2f9f05de46531f
https://www.dovepress.com/clinical-evidence-on-the-efficacy-and-tolerability-of-a-topical-medica-peer-reviewed-article-CCID
https://www.dovepress.com/clinical-evidence-on-the-efficacy-and-tolerability-of-a-topical-medica-peer-reviewed-article-CCID
Autor:
Andrea L. Neimann, Jose U. Scher, Sanja Jelic, Michael S. Garshick, James G. Krueger, Edward A. Fisher, Todd Wechter, Judilyn Fuentes-Duculan, Tessa J. Barrett, Jeffrey S. Berger, Maria Vittoria Cannizzaro, Stuart D. Katz, Sarah Azarchi
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 39:787-798
Objective— Psoriasis is an inflammatory skin disease which heightens the risk of cardiovascular disease. This study directly investigated vascular endothelial health and systemically altered pathways in psoriasis and matched controls. Approach and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1d94e440cc9cfb7c9ac9627b48d06e
https://doi.org/10.1161/atvbaha.118.312246
https://doi.org/10.1161/atvbaha.118.312246
Autor:
Luca Fania, Giulia Giovanardi, Tonia Samela, Dante Caposiena, Andrea Chiricozzi, Flaminia Antonelli, Pierluigi Saraceni, Fulvia Elia, Simone Garcovich, Davide Ciccone, Maria Vittoria Cannizzaro, Emanuele Miraglia, Chiara Iacovino, Sandra Giustini, Nevena Skroza, Alessandra Mambrin, Concetta Potenza, Luca Bianchi, Ketty Peris, Damiano Abeni
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4037
Adalimumab is the only biologic agent approved for the treatment of moderate-to-severe hidradenitis suppurativa (HS) patients (i.e., with Hurley II or III), which is recommended in two different maintenance doses (i.e., 40 mg weekly or 80 mg every tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd3c4d26756bf5e5949dda63b370369
https://doi.org/10.3390/jcm11144037
https://doi.org/10.3390/jcm11144037
Publikováno v:
The American Journal of dermatopathology. 43(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89969c158828b8597aa07606dba68329
https://pubmed.ncbi.nlm.nih.gov/33492843
https://pubmed.ncbi.nlm.nih.gov/33492843
Autor:
Elena Campione, Eleonora Candi, Laura Vollono, Luca Bianchi, Annunziata Dattola, Raffaele Dante Caposiena Caro, Maria Vittoria Cannizzaro, Gennaro Melino, Sara Mazzilli
Publikováno v:
Italian journal of dermatology and venereology. 156(4)
BACKGROUND The efficacy and safety of certolizumab pegol over 52 weeks was compared in two groups of patients: Group 1 comprised patients naive to biologic treatments; Group 2 comprised patients previously treated with one or more antitumor necrosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6732ad32c13dc2da43386515f35649f
https://pubmed.ncbi.nlm.nih.gov/33034437
https://pubmed.ncbi.nlm.nih.gov/33034437
Publikováno v:
Actas Dermo-Sifiliográficas. 110:169-171
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4d3bc7b2573bd5993dd0b8959467eca
https://doi.org/10.1016/j.ad.2018.02.010
https://doi.org/10.1016/j.ad.2018.02.010
Publikováno v:
The American Journal of Dermatopathology. 43:154-155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb23a11dfb149211699fae4f0efe34e
https://doi.org/10.1097/dad.0000000000001647
https://doi.org/10.1097/dad.0000000000001647